Oxidised LDL-lipids increase beta amyloid production by SH-SY5Y cells through glutathione depletion and lipid raft formation

Article English OPEN
Dias, Irundika H.K. ; Mistry, Jayna ; Fell, Shaun ; Reis, Ana ; Spickett, Corinne M. ; Polidori, Maria C ; Lip, Greg Y.H. ; Griffiths, Helen R. (2014)
  • Publisher: Elsevier BV
  • Journal: Free Radical Biology and Medicine, volume 75, pages 48-59 (issn: 0891-5849, eissn: 1873-4596)
  • Related identifiers: doi: 10.1016/j.freeradbiomed.2014.07.012, pmc: PMC4180009
  • Subject: CTB, cholera toxin B | PBS, phosphate-buffered saline | SM, sphingomyelin | GSH, glutathione | BCA, bicinchoninic acid | BSO, buthionine sulfoximine | GSSG, oxidized glutathione | AD, Alzheimer disease | BHT, butylated hydroxytoluene | ASMase, acid sphingomyelinase | Physiology (medical) | EGTA, ethylene glycol tetraacetic acid | Redox | MDA, malondialdehyde | oxLDL, oxidized low-density lipoprotein | PBST, phosphate-buffered saline with 1% Tween 20 | APP, amyloid precursor protein | SDS–PAGE, sodium dodecyl sulfate–polyacrylamide gel electrophoresis | Original Contribution | EDTA, ethylenediamine tetraacetic acid | Cholesterol | 27OH-C, 27-hydroxycholesterol | PVDF, polyvinylidene fluoride | BACE1 | Free radicals | Lipid oxidation | Aβ, β-amyloid | BBB, blood–brain barrier | NAC, N-acetylcysteine | LDL, low-density lipoprotein | Low-density lipoprotein | CSF, cerebrospinal fluid | Lipid raft | Biochemistry | BACE, β-secretase β-site amyloid cleaving enzyme | E-64, proteinase inhibitor E-64 | GCL, glutamate–cysteinyl ligase | Aging | ESI–MS, electrospray ionization mass spectrometry | GSH | ELISA, enzyme-linked immunosorbent assay | OxLDL
    mesheuropmc: lipids (amino acids, peptides, and proteins)

Elevated total cholesterol in midlife has been associated with increased risk of dementia in later life. We have previously shown that low-density lipoprotein (LDL) is more oxidized in the plasma of dementia patients, although total cholesterol levels are not different from those of age-matched controls. β-Amyloid (Aβ) peptide, which accumulates in Alzheimer disease (AD), arises from the initial cleavage of amyloid precursor protein by β-secretase-1 (BACE1). BACE1 activity is regulated by membrane lipids and raft formation. Given the evidence for altered lipid metabolism in AD, we have investigated a mechanism for enhanced Aβ production by SH-SY5Y neuronal-like cells exposed to oxidized LDL (oxLDL). The viability of SH-SY5Y cells exposed to 4 μg oxLDL and 25 μM 27-hydroxycholesterol (27OH-C) was decreased significantly. Lipids, but not proteins, extracted from oxLDL were more cytotoxic than oxLDL. In parallel, the ratio of reduced glutathione (GSH) to oxidized glutathione was decreased at sublethal concentrations of lipids extracted from native and oxLDL. GSH loss was associated with an increase in acid sphingomyelinase (ASMase) activity and lipid raft formation, which could be inhibited by the ASMase inhibitor desipramine. 27OH-C and total lipids from LDL and oxLDL independently increased Aβ production by SH-SY5Y cells, and Aβ accumulation could be inhibited by desipramine and by N-acetylcysteine. These data suggest a mechanism whereby oxLDL lipids and 27OH-C can drive Aβ production by GSH depletion, ASMase-driven membrane remodeling, and BACE1 activation in neuronal cells. © 2014 The Authors.
  • References (53)
    53 references, page 1 of 6

    [1] Ballard, C.; Gauthier, S.; Corbett, A.; Brayne, C.; Aarsland, D.; Jones, E. Alzheimer's disease. Lancet 377:1019-1031; 2011.

    [2] Hussain, I.; Powell, D.; Howlett, D. R.; Tew, D. G.; Meek, T. D.; Chapman, C.; Gloger, I. S.; Murphy, K. E.; Southan, C. D.; Ryan, D. M.; Smith, T. S.; Simmons, D. L.; Walsh, F. S.; Dingwall, C.; Christie, G. Identification of a novel aspartic protease (Asp 2) as beta-secretase. Mol. Cell. Neurosci. 14:419-427; 1999.

    [3] Lambert, J.; Heath, S.; Even, G.; Campion, D.; Sleegers, K.; Hiltunen, M.; Combarros, O.; Zelenika, D.; Bullido, M.; Tavernier, B.; et al. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat. Genet. 41:1094-1099; 2009.

    [4] Hollingworth, P.; Harold, D.; Sims, R.; Gerrish, A.; Lambert, J. C.; Carrasquillo, M. M.; Abraham, R.; Hamshere, M. L.; Pahwa, J. S.; Moskvina, V.; et al. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat. Genet. 43:429-435; 2011.

    [5] Naj, A. C.; Jun, G.; Beecham, G. W.; Wang, L. S.; Vardarajan, B. N.; Buros, J.; Gallins, P. J.; Buxbaum, J. D.; Jarvik, G. P.; Crane, P. K.; et al. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat. Genet. 43:436-441; 2011.

    [6] Chan, R. B.; Oliveira, T. G.; Cortes, E. P.; Honig, L. S.; Duff, K. E.; Small, S. A.; Wenk, M. R.; Shui, G.; Di Paolo, G. Comparative lipidomic analysis of mouse and human brain with Alzheimer disease. J. Biol. Chem. 287:2678-2688; 2012.

    [7] Mapstone, M.; Cheema, A. K.; Fiandaca, M. S. Plasma phospholipids identify antecedent memory impairment in older adults. Nat. Med. 20:415-418; 2014.

    [8] Kalvodova, L.; Kahya, N.; Schwille, P.; Ehehalt, R.; Verkade, P.; Drechsel, D.; Simons, K. Lipids as modulators of proteolytic activity of BACE: involvement of cholesterol, glycosphingolipids, and anionic phospholipids in vitro. J. Biol. Chem. 280:36815-36823; 2005.

    [9] Grimm, M. O.; Grimm, H. S.; Patzold, A. J.; Zinser, E. G.; Halonen, R.; Duering, M.; Tschape, J. A.; De Strooper, B.; Muller, U.; Shen, J.; Hartmann, T. Regulation of cholesterol and sphingomyelin metabolism by amyloid-beta and presenilin. Nat. Cell Biol. 7:1118-1123; 2005.

    [10] Matsuzaki, K.; Kato, K.; Yanagisawa, K. Abeta polymerization through interaction with membrane gangliosides. Biochim. Biophys. Acta 1801:868-877; 2010.

  • Metrics
    No metrics available
Share - Bookmark